Compare

Advanced Biomed Inc. vs YD Bio Ltd vs Aclarion, Inc. vs American Shared Hospital Services

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearAdvanced Biomed Inc.
ADVBRevenue covers only part of its income (partial revenue)
YD Bio Ltd
YDES
Aclarion, Inc.
ACON
American Shared Hospital Services
AMS
Year ended2026-06-302025-12-312025-12-312025-12-31
Revenuen/a$596.8K$75.7K$28.08M
Revenue growth (YoY)n/a+16.9%+65.6%-0.9%
Gross marginn/a28.1%9.0%18.0%
Operating marginn/a-883.3%n/m-12.8%
Net marginn/an/mn/m-5.5%
Net income$6.68M-$8.31M-$7.23M-$1.55M
EPS (Diluted)$5.33-$0.12-$13.61-$0.23
Operating cash flow-$1.95M-$6.60M-$7.16M$3.10M
Free cash flown/a-$8.04M-$7.19M-$4.54M
Cash & equivalentsn/a$6.01M$12.02M$3.46M
Total assets$13.75M$13.78M$13.67M$55.48M
Total liabilities$1.47M$16.64M$837.3K$27.79M
Shareholders' equity$12.28M-$2.86M$12.84M$27.69M
Return on year-end equity54.4%n/a-56.4%-5.6%
Shares outstanding1.65M70.79M854.4K6.58M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearAdvanced Biomed Inc.YD Bio LtdAclarion, Inc.American Shared Hospital Services
Latestn/a$596.8K
Ended 2025-12-31
$75.7K
Ended 2025-12-31
$28.08M
Ended 2025-12-31
1 year earliern/a$510.4K
Ended 2024-12-31
$45.7K
Ended 2024-12-31
$28.34M
Ended 2024-12-31
2 years earliern/a$350.1K
Ended 2023-12-31
$75.4K
Ended 2023-12-31
$21.32M
Ended 2023-12-31
3 years earliern/an/a$60.4K
Ended 2022-12-31
$19.75M
Ended 2022-12-31
4 years earliern/an/a$60.3K
Ended 2021-12-31
$17.63M
Ended 2021-12-31